James A Bonner Selected Research

Chemoradiotherapy

12/2017	Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer.
11/2011	Impact of average weekly dose of radiation during radiotherapy alone or chemoradiotherapy in head and neck cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

James A Bonner Research Topics

Disease

54	Neoplasms (Cancer) 04/2024 - 11/2002
29	Head and Neck Neoplasms (Head and Neck Cancer) 01/2023 - 07/2002
16	Squamous Cell Carcinoma of Head and Neck 11/2022 - 07/2002
10	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2024 - 09/2009
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2014 - 10/2002
7	Carcinoma (Carcinomatosis) 01/2023 - 07/2002
5	Lung Neoplasms (Lung Cancer) 01/2018 - 11/2002
5	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 08/2012 - 07/2004
4	Neoplasm Metastasis (Metastasis) 03/2024 - 03/2011
4	Deglutition Disorders (Dysphagia) 01/2021 - 02/2009
3	Glioblastoma (Glioblastoma Multiforme) 06/2019 - 06/2012
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2009 - 11/2002
2	Pain (Aches) 07/2023 - 01/2021
2	Melanoma (Melanoma, Malignant) 01/2023 - 01/2022
2	Adenocarcinoma 01/2018 - 03/2015
2	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2016 - 11/2011
2	Mucositis 01/2016 - 09/2014
2	Exanthema (Rash) 09/2014 - 01/2010
2	Disease Progression 01/2011 - 02/2006
2	Pathologic Constriction (Stenosis) 02/2010 - 02/2009
1	Persistent Infection 04/2024
1	Oropharyngeal Neoplasms 03/2024
1	Canavan Disease (Leukodystrophy, Spongiform) 01/2024
1	Multiple Myeloma 07/2023
1	Body Weight (Weight, Body) 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 10/2019
1	Triple Negative Breast Neoplasms 09/2019
1	Anorexia 09/2014
1	Hypokalemia 09/2014
1	Fatigue 09/2014
1	Laryngeal Neoplasms (Laryngeal Cancer) 08/2013

Drug/Important Bio-Agent (IBA)

21	Cetuximab (Erbitux)FDA Link 01/2023 - 07/2002
12	ErbB Receptors (EGF Receptor)IBA 01/2020 - 07/2002
10	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 07/2002
6	Biomarkers (Surrogate Marker)IBA 03/2024 - 06/2011
6	Phosphotransferases (Kinase)IBA 11/2022 - 01/2014
6	Monoclonal AntibodiesIBA 03/2022 - 03/2003
5	Immune Checkpoint InhibitorsIBA 01/2024 - 09/2019
5	Proteins (Proteins, Gene)FDA Link 11/2022 - 01/2011
4	Poly(ADP-ribose) Polymerase InhibitorsIBA 09/2015 - 01/2011
4	veliparibIBA 09/2015 - 01/2011
3	tyrosine receptor (receptor, tyrosine)IBA 11/2022 - 03/2015
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 06/2012
3	Epidermal Growth Factor (EGF)IBA 01/2020 - 11/2002
3	Myristoylated Alanine-Rich C Kinase SubstrateIBA 06/2019 - 06/2012
3	Gemcitabine FDA Link 01/2018 - 11/2002
3	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 09/2015 - 01/2011
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2010 - 03/2003
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2022 - 01/2020
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022 - 03/2003
2	olaparibIBA 01/2020 - 09/2012
2	PlatinumIBA 12/2017 - 07/2008
2	Peptides (Polypeptides)IBA 03/2015 - 03/2003
2	P 11 (P-11)IBA 08/2012 - 03/2011
2	Small Interfering RNA (siRNA)IBA 06/2011 - 09/2009
2	BariumIBA 02/2010 - 02/2009
2	Ethylene Glycol (Monoethylene Glycol)IBA 01/2010 - 11/2007
2	Taxoids (Taxanes)IBA 01/2010 - 03/2003
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2007 - 01/2006
2	Tyrosine Kinase InhibitorsIBA 09/2007 - 01/2006
2	Etoposide (VP 16)FDA LinkGeneric 07/2007 - 06/2005
1	ChromatinIBA 04/2024
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2024
1	Acetates (Acetic Acid Esters)FDA Link 01/2024
1	Glycerol (Glycerine)FDA LinkGeneric 01/2024
1	ruxolitinibIBA 01/2022
1	Oxycodone (Oxycontin)FDA LinkGeneric 01/2021
1	LipidsIBA 01/2021
1	8- dibenzothiophen- 4- yl- 2- morpholin- 4- yl- chromen- 4- oneIBA 01/2020
1	LigandsIBA 01/2020
1	AlbuminsIBA 09/2019
1	130-nm albumin-bound paclitaxelIBA 09/2019
1	pembrolizumabIBA 09/2019
1	Phospholipids (Phosphatides)FDA LinkGeneric 06/2019
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 06/2019
1	TensinsIBA 06/2019
1	SialyltransferasesIBA 01/2018
1	antineoplaston A10 (A 10)IBA 09/2015
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 03/2015
1	Endothelial Growth FactorsIBA 08/2014
1	pazopanib FDA Link 08/2014
1	Temozolomide (Temodar)FDA LinkGeneric 06/2014

Therapy/Procedure

47	Radiotherapy 03/2024 - 07/2002
17	Drug Therapy (Chemotherapy) 03/2024 - 07/2002
16	Therapeutics 01/2024 - 05/2003
6	Gastrostomy 01/2021 - 02/2009
4	Re-Irradiation 01/2019 - 01/2018
4	Enteral Nutrition (Feeding, Tube) 01/2018 - 03/2012
3	Immunotherapy 01/2023 - 09/2019
3	Combined Modality Therapy 01/2021 - 09/2003
3	Aftercare (After-Treatment) 01/2011 - 06/2007
3	Cranial Irradiation 01/2011 - 07/2007
2	Precision Medicine 09/2019 - 01/2014
2	Tracheostomy 01/2018 - 01/2018
2	Chemoradiotherapy 12/2017 - 11/2011
1	Retreatment 07/2023
1	Pain Management 01/2021
1	Microspheres (Microsphere) 01/2021
1	Analgesia 01/2021
1	Particle Accelerators 11/2013